Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

480P CATRIPCA – A phase I of pembrolizumab (P) combined with Xevinapant (Debio 1143, (X)) in patients (pts) with non MSI-high advanced/metastatic pancreatic ductal adenocarcinoma (PDAC) or colorectal cancer (CRC)

Autor: P.A. Cassier, C. Terret, A. Voisin, C. Schiffler, A-S. Bidaux, H. Vanacker, L. Eberst, M.W. Lepercq, A. D'Argenio, null M. Bernardin, A. Bouhamama, L. Gilles-Afchain, I. Treilleux, S. Tabone-Eglinger, D. Spaggiari, S. Chabaud, Y. Grinberg-Bleyer, G. Garin, D. Perol, A. Vinceneux

Publikováno v: Annals of Oncology. 33:S759

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::10e5e4227217e951f4974ec714fb1961
https://doi.org/10.1016/j.annonc.2022.07.608

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Long-term efficacy of imatinib mesylate in patients with advanced Tenosynovial Giant Cell Tumor

Autor: Gerjon Hannink, L. Eberst, Floortje G M Verspoor, J.-Y. Blay, Anthony D. Wagner, Jayesh Desai, Monique J L Mastboom, W.T.A. van der Graaf, Emmanuelle Bompas, Antoine Italiano, Silvia Stacchiotti, Beatrice Seddon, M. A. J. van de Sande, Mehdi Brahmi, Robert G. Maki, Hans Gelderblom, Olivier Mir, Philippe A. Cassier

Publikováno v: Scientific Reports, 9. NATURE PUBLISHING GROUP
Scientific Reports, 9
Scientific reports, 9(1):14551. Nature Publishing Group
Scientific Reports, Vol 9, Iss 1, Pp 1-8 (2019)
Scientific Reports

Tenosynovial giant cell tumors (TGCT), are rare colony stimulating factor-1(CSF-1)-driven proliferative disorders affecting joints. Diffuse-type TGCT often causes significant morbidity due to local recurrences necessitating multiple surgeries. Imatin

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::512658e5aad64a059b03299956ac73d9
https://doi.org/10.1038/s41598-019-51211-y

A phase I dose escalation trial evaluating the impact of an in situ immunization strategy with intra-tumoral injections of Pexa-Vec in combination with ipilimumab in advanced solid tumors with injectable lesions

Autor: A. Marabelle, L. Eberst, C. Terret, F. Pilleul, C. Mastier, A. Bouhamama, L. Gilles-Afchain, S. Laurent, I. Delzano, C. Reynaud, C. Caux, G. Garin, A.-S. Bidaux, D. Perol, N. Stojkowitz, M. Homerin, H. Leenders, P. Cassier

Publikováno v: Annals of Oncology. 29:x38

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::b5b5269ed201349eab3ae7f8d2b19734
https://doi.org/10.1093/annonc/mdy487.041